Michael I. Koukourakis

Author

Also Known As

Koukourakis, Michael I, Koukourakis, Michael I., M I Koukourakis, M KOUKOURAKIS, M Koukourakis, M. I. Koukourakis, M. KOUKOURAKIS, M. Koukourakis, M.I Koukourakis, M.I. Koukourakis

378

Publications

19.7K

Citations

H-Index

127

Concepts

All Affiliations

Democritus University of Thrace John Radcliffe Hospital Forthnet (Greece)Cancer Research UK University Hospital of Alexandroupolis

About

Michael I. Koukourakis is an author at Democritus University of Thrace specializing in medicine, tumor biology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	44	110	9.9K
2	Health Sciences	20	28	1.2K
3	Allergy	3	3	4.2K
4	Engineering	2	2	25
5	Natural Sciences	1	1	4K

Michael I. Koukourakis

217

Publications

17.8K

Citations

H-Index

Page 1

	Year	Citations
Guidelines for the use and interpretation of assays for monitoring autophagy Daniel J. Klionsky, Fábio Camargo Abdalla, Hagai Abeliovich, Autophagy MitophagyParticular Autophagy AssaysImmunologyCytoskeletonMultiple Assays	2012	4K
Relation of hypoxia inducible factor 1α and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival Alexandra Giatromanolaki, Michael I. Koukourakis, Efthimios Sivridis, British Journal of Cancer	2001	469
Comparison of Metabolic Pathways between Cancer Cells and Stromal Cells in Colorectal Carcinomas: a Metabolic Survival Role for Tumor-Associated Stroma Michael I. Koukourakis, Alexandra Giatromanolaki, Adrian L. Harris, Cancer Research	2006	433
Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis Michael I. Koukourakis, Alexandra Giatromanolaki, Efthimios Sivridis, British Journal of Cancer	2003	377
Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer Michael I. Koukourakis, Alexandra Giatromanolaki, Efthimios Sivridis, International Journal of Radiation OncologyBiologyPhysics Hypoxia-inducible FactorMedicineHead And Neck CancerCancer TreatmentNeck Oncology	2002	350
Mean platelet volume: a useful marker of inflammatory bowel disease activity Andreas Kapsoritakis, Michael I. Koukourakis, Aekaterini Sfiridaki, The American Journal of Gastroenterology	2001	343
Endogenous Markers of Two Separate Hypoxia Response Pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) Are Associated With Radiotherapy Failure in Head and Neck Cancer Patients Recruited in the CHART Randomized Trial Michael I. Koukourakis, Søren M. Bentzen, Alexandra Giatromanolaki, Journal of Clinical Oncology	2006	294
Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer Kenneth J. O’Byrne, Michael I. Koukourakis, Alexandra Giatromanolaki, British Journal of Cancer	2000	277
Subcutaneous Administration of Amifostine During Fractionated Radiotherapy: A Randomized Phase II Study Michael I. Koukourakis, George Kyrias, S. Kakolyris, Journal of Clinical Oncology	2000	272
Lactate dehydrogenase 5 (LDH5) relates to up-regulated hypoxia inducible factor pathway and metastasis in colorectal cancer Michael I. Koukourakis, Alexandra Giatromanolaki, C. Simopoulos, Clinical & Experimental Metastasis Lactate Dehydrogenase 5Tumor BiologyOncologyMedicineColorectal Cancer	2005	233

Page 1